BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1884374)

  • 21. Clinical significance of hTERC and C-Myc genes amplification in a group of Egyptian patients with cancer cervix.
    Eid MM; Nossair HM; Ismael MT; Amira G; Hosney MM; Abdul Rahman R
    Gulf J Oncolog; 2011 Jul; (10):18-26. PubMed ID: 21724525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
    Milde-Langosch K; Wilckens C; Brack T; Löning T
    Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
    Wegman P; Ahlin C; Sorbe B
    Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotype of mutant ras p21 and early response to radiotherapy in cancer of the uterine cervix.
    Sreelekha TT; Nair MK; Jayaprakash PG; Pillai MR
    J Exp Clin Cancer Res; 1999 Sep; 18(3):337-41. PubMed ID: 10606179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetics of uterine cervical cancer: application to prognosis].
    Riou G
    Rev Prat; 1990 Jan; 40(3):239-41. PubMed ID: 2406878
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenes in gynecologic malignancy.
    Baker V
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The possibility of viral etiology in cervical carcinogenesis].
    Iwasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.
    Shim C; Zhang W; Rhee CH; Lee JH
    Clin Cancer Res; 1998 Dec; 4(12):3045-50. PubMed ID: 9865919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
    Huang G; Xiao X; Huang Y; Huang R
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
    Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
    Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer.
    Liao LM; Sun XY; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M; Huang L
    Gynecol Oncol; 2014 Jun; 133(3):616-23. PubMed ID: 24667250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
    Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
    Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
    Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
    Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix.
    Pinion SB; Kennedy JH; Miller RW; MacLean AB
    Lancet; 1991 Apr; 337(8745):819-20. PubMed ID: 1672915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
    Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
    C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.